Kenneth Ph.D. Harrison - 08 Apr 2021 Form 4/A - Amendment Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Director
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
08 Apr 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
26 May 2021, 18:01:54 UTC
Date Of Original Report
12 Apr 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RPHM Stock Option (right to buy) 0 08 Apr 2021 Common Stock Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 12, 2021, the reporting person mistakenly filed a Form 4 reporting a grant of a stock option (right to buy) of 14,000 shares that did not in fact occur.